UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000019710
Receipt No. R000022763
Scientific Title A retrospective study of treatments and prognosis of neuroendocrine tumor of endometrium
Date of disclosure of the study information 2015/11/09
Last modified on 2019/11/12 (Ver. 9)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A retrospective study of treatments and prognosis of neuroendocrine tumor of endometrium
Acronym A retrospective study of neuroendocrine tumor of endometrium
Scientific Title A retrospective study of treatments and prognosis of neuroendocrine tumor of endometrium
Scientific Title:Acronym A retrospective study of neuroendocrine tumor of endometrium
Region
Japan

Condition
Condition Neuroendocrine tumor of endometrium
Classification by specialty
Obsterics and gynecology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To clarify treatment and prognosis of neuroendocrine tumor of endometrium, and to obtain findings to establish future individualized treatment.
Basic objectives2 Others
Basic objectives -Others Retrospective observational study
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes background factors, stage, tratments, pathological findings, prognosis
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria Patients diagnosed with neuroendocrine tumor of endometrium between 1995 and 2014.
Key exclusion criteria 1) Patients with a history of chemotherapy and/or radiotherapy for other malignancy.
2) Patients with a severe complication.
3) Patients who have other malignancies.
Target sample size 30

Research contact person
Name of lead principal investigator
1st name Harunobu
Middle name
Last name Matsumoto
Organization Faculty of Medicine, Oita University
Division name Department of Obstetrics and Gynecology
Zip code 8795593
Address 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 8795593, Japan
TEL 097-586-5922
Email matumoti@oita-u.ac.jp

Public contact
Name of contact person
1st name Harunobu
Middle name
Last name Matsumoto
Organization Faculty of Medicine, Oita University
Division name Department of Obstetrics and Gynecology
Zip code 8795593
Address 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita 8795593, Japan
TEL 097-586-5922
Homepage URL
Email matumoti@oita-u.ac.jp

Sponsor
Institute Kansai Clinical Oncology Group
Institute
Department

Funding Source
Organization Kansai Clinical Oncology Group
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University
Address 1-1, Idaigaoka, Hasama-machi, Yufu-shi, Oita 8795593, Japan
Tel 097-586-5120
Email syomu@oita-u..ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 11 Month 09 Day

Related information
URL releasing protocol http://www.med.oita-u.ac.jp/sanka/patient/index5.html
Publication of results Published

Result
URL related to results and publications https://www.ejgo.org/DOIx.php?id=10.3802/jgo.2019.30.e103
Number of participants that the trial has enrolled 42
Results
Please refer to the link below.

https://www.ejgo.org/DOIx.php?id=10.3802/jgo.2019.30.e103
Results date posted
2019 Year 05 Month 13 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
2019 Year 07 Month 01 Day
Baseline Characteristics
Please refer to the link below.

https://www.ejgo.org/DOIx.php?id=10.3802/jgo.2019.30.e103
Participant flow
Please refer to the link below.

https://www.ejgo.org/DOIx.php?id=10.3802/jgo.2019.30.e103
Adverse events
Not applicable
Outcome measures
Please refer to the link below.

https://www.ejgo.org/DOIx.php?id=10.3802/jgo.2019.30.e103
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 07 Month 24 Day
Date of IRB
2015 Year 07 Month 24 Day
Anticipated trial start date
2015 Year 11 Month 01 Day
Last follow-up date
2016 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information This is a multi-center retrospective study.

Management information
Registered date
2015 Year 11 Month 09 Day
Last modified on
2019 Year 11 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022763